Hot topics close

TD Bank Earnings: Weak Results Due to US Operations and High Insurance Expenses

TD Bank Earnings Weak Results Due to US Operations and High Insurance 
Expenses
We see TD Bank stock as undervalued.

Toronto-Dominion Bank TD reported weaker-than-expected fiscal fourth-quarter results on higher costs as it works to put its regulatory issues in the US behind it. Adjusted net revenue increased 12.5% to C$14.9 billion while adjusted net income fell 8% from last year to C$3.2 billion. These results translate to a return on equity of 11.7%, below the firm’s historical performance. TD Bank also suspended its medium-term financial targets of 7%-10% earnings per share growth and a 16% return on equity. While this was unsurprising after the asset cap placed on its US operations, which will be a headwind for growth, it is still disappointing. That said, we do not expect to materially alter our fair value estimate of C$88 per share.

Key Morningstar Metrics for TD Bank

Once again, the Canadian personal and commercial banking segment was a source of strength, with net income rising 9% to C$1.8 billion. This was entirely due to higher net interest income, which increased 9.5% to C$4.06 billion. The segment saw solid loan growth, with average loans rising just under 5% to C$578 billion. Additionally, net interest margin expanded to 2.80% from 2.78%. This is below the high of 2.84% seen earlier in the year, but as interest rates in Canada fall, we expect the bank’s net interest margin to stay relatively stable.

US operations were a headwind to TD Bank’s overall results, with adjusted net income falling 13%. As part of the fallout from its anti-money-laundering issues in the United States, the firm is reducing its assets there by 10% and restructuring its investment portfolio. The excess liquidity from this process led US net interest margin to fall 25 basis points quarter over quarter to 2.77%. To make matters worse, the bank saw further deterioration in credit quality; US retail provisioning expenses increased to C$389 million from C$289 million last year.

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar's editorial policies.

Similar news
News Archive
  • Amyotrophic lateral sclerosis
    Amyotrophic lateral sclerosis
    NeuroSense Announces Peer-Reviewed Publication of PrimeC Phase IIa ALS Study in Amyotrophic Lateral Sclerosis ...
    19 Sep 2022
    4
  • Belle
    Belle
    AVEZ-VOUS SOUMIS VOTRE CANDIDATURE? CONCOURS « LA ...
    24 Oct 2024
    1
  • Bloating
    Bloating
    Bloating to heartburn; 6 telltale signs of an unhealthy gut
    7 Apr 2024
    1
  • Shake Milton
    Shake Milton
    How Milton went from summer league disappointment to tying NBA record
    2 Mar 2020
    5